Prime Medicine, Inc.

NasdaqGM:PRME Stock Report

Market Cap: US$607.6m

Prime Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:PRME Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Feb 24BuyUS$20,000,000Arch Venture Partners, L.P.Company3,200,000US$6.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PRME?
Owner TypeNumber of SharesOwnership Percentage
Private Companies21,0110.0182%
Public Companies1,608,3371.4%
General Public14,908,00412.9%
Individual Insiders25,676,02122.3%
Institutions36,454,67331.6%
VC/PE Firms36,624,77131.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.5%.


Top Shareholders

Top 25 shareholders own 83.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.5%
David Liu
20,156,945US$106.2m0%no data
13.4%
Arch Venture Partners, L.P.
15,456,594US$81.5m26.1%5.55%
13.1%
GV Management Company, LLC
15,062,498US$79.4m27%6.34%
5.3%
Newpath Management, L.P.
6,105,679US$32.2m15.1%no data
5.2%
ARK Investment Management LLC
5,993,354US$31.6m91%0.22%
3.78%
Keith Gottesdiener
4,361,078US$23.0m0%no data
3.52%
The Vanguard Group, Inc.
4,054,911US$21.4m2.61%no data
3.4%
Impresa Management LLC
3,921,507US$20.7m0%7.8%
3.28%
BlackRock, Inc.
3,778,618US$19.9m13.3%no data
2.92%
Nikko Asset Management Co., Ltd.
3,364,663US$17.7m-4.39%0.01%
1.93%
T. Rowe Price Group, Inc.
2,221,159US$11.7m2.2%no data
1.55%
Mwg Management Ltd.
1,792,210US$9.4m0%8.07%
1.4%
Beam Therapeutics Inc.
1,608,337US$8.5m0%no data
1.15%
Redmile Group, LLC
1,324,350US$7.0m0%0.26%
0.89%
Baker Bros. Advisors LP
1,028,466US$5.4m0%0.06%
0.84%
Jeremy Duffield
965,001US$5.1m0%no data
0.77%
Geode Capital Management, LLC
887,503US$4.7m4.83%no data
0.77%
Deerfield Management Company, L.P. Series C
885,314US$4.7m0%0.08%
0.66%
State Street Global Advisors, Inc.
759,758US$4.0m-54.9%no data
0.44%
Greenwich Wealth Management, LLC
513,001US$2.7m16.9%0.21%
0.41%
Samsara BioCapital LLC
470,304US$2.5m0%0.44%
0.34%
Bank of America Corporation, Asset Management Arm
397,246US$2.1m54.5%no data
0.32%
Casdin Capital, LLC
367,175US$1.9m0%0.15%
0.31%
The Bollard Group, LLC
361,136US$1.9m0%0.05%
0.3%
Northern Trust Global Investments
344,927US$1.8m3.59%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.